Detalles de la búsqueda
1.
Characterization of HER2-low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study.
Cancer;
2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38752572
2.
Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.
JAMA;
331(13): 1135-1144, 2024 04 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38563834
3.
Pregnancy After Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study.
JAMA;
331(1): 49-59, 2024 01 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38059899
4.
Radiological response of leptomeningeal metastases according to revised RANO criteria is associated with overall survival in breast cancer patients.
Int J Cancer;
153(6): 1217-1226, 2023 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37243480
5.
Prognostic impact of extracranial disease control in HER2+ breast cancer-related brain metastases.
Br J Cancer;
128(7): 1286-1293, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36717671
6.
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation.
Br J Cancer;
128(2): 266-274, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36396818
7.
Characterization of Gut Microbiome Composition in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy.
Oncologist;
28(9): e703-e711, 2023 09 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36940301
8.
The Impact of COVID-19 on Treatment Practices for Patients With Early Breast Cancer: A Cross-Sectional Study From a Large Cancer Center in Italy.
Oncologist;
28(12): e1179-e1184, 2023 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37699107
9.
Leptomeningeal metastases in patients with human epidermal growth factor receptor 2 positive breast cancer: Real-world data from a multicentric European cohort.
Int J Cancer;
151(8): 1355-1366, 2022 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35666525
10.
Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer.
Oncologist;
25(9): e1355-e1362, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32618068
11.
Olaparib for advanced breast cancer.
Future Oncol;
16(12): 717-732, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32249603
12.
Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study.
Breast J;
26(7): 1296-1301, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31837103
13.
The Tumor Microenvironment of Primitive and Metastatic Breast Cancer: Implications for Novel Therapeutic Strategies.
Int J Mol Sci;
21(21)2020 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33143050
14.
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.
Semin Cancer Biol;
52(Pt 2): 16-25, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29024776
15.
Programmed Cell Death Ligand 1 in Breast Cancer: Technical Aspects, Prognostic Implications, and Predictive Value.
Oncologist;
24(11): e1055-e1069, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31444294
16.
Impact of 21-Gene Breast Cancer Assay on Treatment Decision for Patients with T1-T3, N0-N1, Estrogen Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer: Final Results of the Prospective Multicenter ROXANE Study.
Oncologist;
24(11): 1424-1431, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31152079
17.
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial.
BMC Med;
17(1): 207, 2019 11 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31747948
18.
Escalation and de-escalation in HER2 positive early breast cancer.
Curr Opin Oncol;
31(1): 35-42, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30325338
19.
Immune characterization of breast cancer metastases: prognostic implications.
Breast Cancer Res;
20(1): 62, 2018 06 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-29929548
20.
Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation.
Br J Cancer;
128(2): 398, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36460777